Pelthos (PTHS) director’s 558-share tax sale under Rule 10b5-1 plan
Rhea-AI Filing Summary
Pelthos Therapeutics director Ezra M. Friedberg reported small open‑market sales of Pelthos common stock. On April 2, 2026, he sold 293 shares at $20.5121 and 265 shares at $21.3612, totaling 558 shares. These transactions were made under a Rule 10b5-1 trading plan adopted on December 16, 2025 to help cover estimated tax obligations from vesting restricted stock units.
After the sales, Friedberg held 82,027 common shares directly82,072 shares held indirectly by Balmoral Financial Group LLC and 40,000 shares held indirectly by Key Recovery Group LLC, entities for which he is manager and may be deemed a beneficial owner to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Director’s 558-share sale is small, tax-driven, and pre-planned.
The filing shows director Ezra M. Friedberg sold 558 Pelthos common shares on April 2, 2026 at prices around $20–$21 per share. The footnotes state the trades were executed under a Rule 10b5-1 plan adopted on December 16, 2025 to satisfy estimated tax obligations from restricted stock unit vesting.
This indicates a routine, compensation-related transaction rather than a discretionary market-timing sale. After these trades, he still directly holds 82,027 shares, and the filing lists additional indirect holdings via Balmoral Financial Group LLC and Key Recovery Group LLC, with beneficial ownership disclaimed except for his pecuniary interest. Overall, the scale and purpose point to a neutral signal for shareholders.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 293 | $20.5121 | $6K |
| Sale | Common Stock | 265 | $21.3612 | $6K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- This transaction reflects the sale of shares, made pursuant to a Rule 10b5-1 plan adopted December 16, 2025, for the purpose of satisfying estimated tax obligations in connection with the vesting of restricted stock units granted by the Issuer. This transaction was executed in multiple trades at prices ranging from $20.30 to $20.78. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $21.31 to $22.03. The price reported in column 4 above reflects the weighted average price of the shares of Common Stock sold. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Ezra Friedberg is the manager of Balmoral Financial Group LLC ("Balmoral") and the manager of Key Recovery Group LLC ("Key"). By virtue of this relationship, Mr. Friedberg may be deemed to beneficially own the shares of Common Stock held of record by each of Balmoral and Key. Mr. Friedberg disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.